News from IrsiCaixa

All the news in a click

Announcement on the new SARS-CoV-2 strain, variant VUI-202012/01

Pre-clinical studies confirm that the CPC component of some mouthwashes reduces the infectivity of SARS-CoV-2

Protective antibodies against COVID-19 are maintained for a minimum of six months

25 years of research: a story in between pandemics, from AIDS to COVID-19

Rapid antigen test detects SARS-CoV-2 even in asymptomatic people

The first projects on SARS-CoV-2 in lab-designed mini human organs gets underway

Green light for clinical trial to study the efficacy of convalescent plasma as a treatment for COVID-19

IrsiCaixa will sign a collaboration agreement with IRTA to study emerging zoonotic diseases

Promoted by:

'La Caixa' Foundation

Member of:

In cooperation with: